XF
GSK icon

XML Financial’s GSK GSK Stock Holding History

XML Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$796K Sell
15,185
-550
-3% -$29.1K 0.06% 213
2026
Q1 		$868K Sell
15,735
-3,553
-18% -$193K 0.07% 195
2025
Q4 		$946K Buy
19,288
+2,393
+14% +$112K 0.08% 184
2025
Q3 		$729K Sell
16,895
-910
-5% -$35.5K 0.06% 211
2025
Q2 		$684K Buy
17,805
+210
+1% +$8.02K 0.06% 210
2025
Q1 		$682K Sell
17,595
-5,953
-25% -$218K 0.06% 194
2024
Q4 		$796K Sell
23,548
-1,386
-6% -$49.9K 0.07% 188
2024
Q3 		$1.02M Sell
24,934
-1,061
-4% -$43.4K 0.09% 174
2024
Q2 		$1M Sell
25,995
-1,958
-7% -$82.4K 0.1% 165
2024
Q1 		$1.2M Sell
27,953
-3,334
-11% -$137K 0.12% 149
2023
Q4 		$1.16M Sell
31,287
-1,266
-4% -$45.4K 0.12% 147
2023
Q3 		$1.18M Buy
32,553
+8
+0% +$284 0.14% 138
2023
Q2 		$1.16M Sell
32,545
-461
-1% -$16.5K 0.13% 145
2023
Q1 		$1.17M Buy
33,006
+292
+0.9% +$10.2K 0.14% 140
2022
Q4 		$1.15M Sell
32,714
-78
-0.2% -$2.6K 0.14% 137
2022
Q3 		$965K Buy
+32,792
New +$1.24M 0.13% 140
2022
Q2 		– Sell
-28,118
Closed -$1.53M – 275
2022
Q1 		$1.53M Sell
28,118
-1,013
-3% -$55K 0.18% 120
2021
Q4 		$1.61M Buy
29,131
+309
+1% +$16.1K 0.19% 117
2021
Q3 		$1.38M Buy
+28,822
New +$1.45M 0.18% 124

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XML Financial's GSK Position: Q2 2026 in Review

XML Financial reduced its GSK (GSK) stake by 3.5% in Q2 2026, selling an estimated $29.1K and leaving 15,185 shares worth $796K. The position accounts for 0.06% of the portfolio, ranked #213.

XML Financial first reported a position in GSK in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.61M in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • XML Financial held 15,185 shares of GSK worth $796K as of Q2 2026.
  • XML Financial sold 550 GSK shares in Q2 2026, an estimated $29.1K.
  • GSK made up 0.06% of XML Financial's portfolio in Q2 2026, its #213 holding.
  • XML Financial first reported a position in GSK in Q3 2021 and has held it in 19 quarters since.
  • XML Financial's GSK position peaked at $1.61M in Q4 2021.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.